Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)
NCT05575167
·
clinicaltrials.gov ↗
RECRUITING
Status
125
Enrollment
OTHER
Sponsor class
Conditions
Osteoporosis, Postmenopausal
Interventions
DRUG:
Zoledronate or Alendronate
Sponsor
424 General Military Hospital